Cargando…
Gabra2 is a genetic modifier of Dravet syndrome in mice
Pathogenic variants in epilepsy genes result in a spectrum of clinical severity. One source of phenotypic heterogeneity is modifier genes that affect expressivity of a primary pathogenic variant. Mouse epilepsy models also display varying degrees of clinical severity on different genetic backgrounds...
Autores principales: | Hawkins, Nicole A., Nomura, Toshihiro, Duarte, Samantha, Barse, Levi, Williams, Robert W., Homanics, Gregg E., Mulligan, Megan K., Contractor, Anis, Kearney, Jennifer A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458207/ https://www.ncbi.nlm.nih.gov/pubmed/34086081 http://dx.doi.org/10.1007/s00335-021-09877-1 |
Ejemplares similares
-
Soticlestat, a novel cholesterol 24‐hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice
por: Hawkins, Nicole A., et al.
Publicado: (2021) -
Fine mapping and candidate gene analysis of a dravet syndrome modifier locus on mouse chromosome 11
por: Kearney, Jennifer A., et al.
Publicado: (2022) -
A quantitative trait variant in Gabra2 underlies increased methamphetamine stimulant sensitivity
por: Goldberg, Lisa R., et al.
Publicado: (2021) -
Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq
por: Hawkins, Nicole A., et al.
Publicado: (2016) -
Dravet syndrome-associated mutations in GABRA1, GABRB2 and GABRG2 define the genetic landscape of defects of GABA(A) receptors
por: Hernandez, Ciria C, et al.
Publicado: (2021)